Akash Shah is Chief Growth Officer and Global Head of Growth Ventures. He is also a member of the BNY Executive Committee.

NEW YORK, July 21, 2021 /PRNewswire/ -- The Bank of New York Mellon Corporation ("BNY Mellon") (NYSE: BK) announced today that Akash Shah has been appointed Chief Growth Officer, effective immediately. This newly created role will oversee Strategy, Marketing & Communications, and Global Client Management.

Akash Shah, MD, is a fellowship-trained Orthopaedic Surgeon specializing in Hip and Knee reconstruction. Dr. Akash Shah graduated Summa Cum Laude with a Bachelor of Arts in Biochemistry and Molecular Biology from Boston University.

Akash is an associate in the firm’s Washington, DC office and a member of the Government Contracts and Life Sciences Transactions Practice Groups. Akash also maintains an active pro bono practice focused on civil rights and immigration matters.

Aug 3, 2022 · Akash Shah is Senior Executive Vice President and Chief Growth Officer. He is also a member of the company’s Executive Committee. As Chief Growth Officer, Akash oversees firm-wide Strategy, Marketing & Communications, and Global Client Management.

Jun 24, 2024 · We recently asked Shah about BNY’s approach to adopting AI, challenges that lie ahead, and what advice he would give to fintech startup founders. Below is an edited excerpt from our conversation. a16z: How is BNY adopting AI, and where has it been most impactful so far?

Akash Shah is Senior Exec VP/Chief Growth Officer at The Bank of New York. See Akash Shah's compensation, career history, education, & memberships.

Dr. Akash Shah, MD, is an Orthopedic Surgeon at SARH. He is an expert in Hip Replacement using the anterior approach. He is also an expert in Knee Replacement and Partial Knee Replacement using minimally invasive techniques.